LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.
Guest: Cassandra Willyard
Host: Lizzie O'Leary
Hosted on Acast. See acast.com/privacy for more information.
